A "movement" worth making: why and how Transfusion Services can play a role in Fecal Microbiota Transplant programs

Area of Science:

• Microbiology and Immunology
• Transfusion Medicine
• Gastroenterology

Background:

• Fecal Microbiota Transplantation (FMT) is a promising therapy, especially for recurrent Clostridioides difficile infections (rCDI).
• Challenges to widespread FMT adoption include complex donor recruitment, rigorous screening, and high-quality stool biobanking.
• Integrating FMT into transfusion medicine offers a potential solution to these logistical hurdles.

Purpose of the Study:

• To explore the integration of FMT programs within transfusion medicine departments.
• To assess the feasibility of leveraging transfusion services' expertise for FMT donor management and biobanking.
• To examine how regulatory frameworks like EU SoHO regulations can support FMT scaling.

Main Methods:

• Review of current FMT program challenges.
• Analysis of transfusion medicine department capabilities in donor screening and biological material processing.
• Discussion of regulatory impacts on stool banking.

Main Results:

• Transfusion medicine departments possess transferable expertise beneficial for FMT programs.
• Despite low donor eligibility rates, collaborative models can enhance FMT accessibility.
• EU SoHO regulations provide a framework for standardized and safer stool banking.

Conclusions:

• Integrating FMT into transfusion medicine is a viable model for expanding patient access.
• Standardized protocols and regulatory compliance are crucial for safe and effective FMT scaling.
• Collaboration across hospital departments is key to overcoming FMT implementation barriers.